2020 has redefined disruption. But it has also brought out the collective spirit of the pharma industry as new partnerships were created, new ways of dealing with challenges were discovered.
Faced with the task of finding a vaccine for COVID-19, while keeping up the supply of lifesaving drugs with a severely strained supply chain, the pharma industry has shown incredible resilience.
We’re looking forward to continuing to drive our industry forward, connect our communities and support businesses, together. Be sure to sign up to get notified when CPhI North America 2021 registration opens!
Exhibition
7 strategic zones, housing the entire pharma supply chain charged to do business
Conference
3 conference tracks across Drug Manufacturing - Drug Delivery & Development - BioProduction
The Live Pharma Connect Match & Meet portal automatically matches you with exhibitors offering just the products and solutions you’re looking for. You can prearrange meetings with the companies that are relevant to you and optimize your three days at the show.
Our 2021 Pharma Outlook report has been published in collaboration with some of Pharma’s biggest names to provide key insights that will help you navigate the next 12 months and grow your business.
Biopharma comprises 25% of the total pharma market and revenues have gone up by over 6000% from the 1990s to now. What are companies doing to keep up with this growth and innovation? Read this article to find out.
How is biopharma striking a balance between modernizing drug development & delivery and the effort to rein in R&D expenses? While change is unlikely to be quick, there is consensus that pharma does need to embrace changes in drug development and delivery fully explore the wide range of opportunities that exist.
Pipeline diversification, emerging therapies and shifting customer demands are the real dynamics reshaping the contract manufacturing market, according to experts. Almost every article written about contracting reports that demand for outsourced manufacturing services is growing and states that the CDMO sector is consolidating.